van Dongen, Johanna MPersoon, SaskiaJongeneel, GabrielleBosmans, Judith EKersten, Marie JoséBrug, JohannesNollet, FransChinapaw, Mai J MBuffart, Laurien M2019-10-212019-10-212019-08-011932-22673128638710.1007/s11764-019-00775-9http://hdl.handle.net/10029/623351One hundred nine patients were randomly assigned to the exercise intervention (n = 54) or the usual care control group (n = 55). Data on cardiorespiratory fitness (VO2peak), handgrip strength, general fatigue, and health-related quality of life (quality-adjusted life years [QALYs]) were collected at baseline (T0), after completion of the exercise intervention or at a similar time point in the control group (T1) and 12 months later (T2). Cost questionnaires were used to assess societal costs. Long-term effectiveness (at T2) was evaluated using linear mixed model analyses. For the economic evaluation, missing data were imputed using multiple imputation, and data were analyzed using linear mixed models.enCost-effectivenessExercise interventionLong-term effectivenessLymphomaMultiple myelomaArticleJ Cancer Surviv 2019; advance online publication (ahead of print)